Tela Bio Inc (TELA) Annual Balance Sheets

Annual · GAAP · USD millions
Access TELA quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Tela Bio Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent50.85
Cash & Short-term Investments50.00
Accounts receivable10.35
Inventories11.02
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.37
Total Current Assets75.58
Equipment/Property/Plant Net2.23
Intangible Assets1.36
Other Assets, Noncurrent2.25
Total Assets81.42
Liabilities
Accounts Payable, Current AC2.31
Accrued Liabilities, Current AC15.67
Total Current Liabilities17.98
Long-term debt55.65
Total Long-term Debt55.65
Other liabilities, Noncurrent1.48
Accrued And Other Liabilities Current-
Total Liabilities75.11
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock403.74
Retained Earnings / Accumulated Deficit-397.56
Other Equity0.09
Common Stockholder's Equity6.31
Total Stockholder's Equity6.31
Liabilities & Stockholder's Equity81.42
4 historic quarters locked

Sign in to unlock the full Tela Bio Inc balance sheet history.

About Tela Bio Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-034507

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License